Pupil Bio, Inc.
TX · Founded 2022 · CIK 0001978510 · Biotech · Private
Cell-free DNA methylation sequencing assay for early detection of pancreatic beta cell death in Type 1 diabetes
pupil.bio →- Grants
- $250K
- 1 award
- Sector median: 1
- Raised
- $500K
- 1 Form D · May 2023
- 41 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 6
- 0 granted · 6 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2022202320242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $500,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of an early detection test for Type 1 Diabetes via NGS-based analysis of β cells-specific methylation patterns in cfDNA | $250,464 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1813 | MDI Therapeutics Investors, LLC | — | — |
| 1814 | Rectify | — | — |
| 1815 | Phylo | — | — |
| 1816 | Pupil Bio, Inc. | — | $500K |
| 1817 | Hapten Sciences, Inc. | — | $2.7M |
| 1818 | REVIVA PHARMACEUTICALS HOLDINGS, INC. | — | — |
| 1819 | KYRON, INC. | — | $3.0M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Bonnie WangExecutive Officer
- David ZhangDirector · Executive Officer
Patents
- Phase Methylation-based Markers For Tissue And Cell-type-specific Identification And Monitoringapplication
- Systems And Methods For Primer Design Via Degenerate Incomplete Multiplex Primer List Expansion (dimple)application
- Phased Methylation-based Markers For Tissue And Cell-type-specific Identification And Monitoringapplication
- Systems And Methods For Primer Design Via Degenerate Incomplete Multiplex Primer List Expansion (dimple)application
- Systems And Methods For Primer Design Via Degenerate Incomplete Multiplex Primer List Expansion (dimple)application
- Phase Methylation-based Markers For Tissue And Cell-type-specific Identification And Monitoringapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.